Cassava Sciences Inc
NASDAQ:SAVA
Cassava Sciences Inc
NASDAQ:SAVA
Price:
1.82
USD
-4.71%
Market Closed
Market Cap:
$87.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Cassava Sciences Inc
NASDAQ:SAVA
|
US |
|
S
|
SoulBrain Co Ltd
KOSDAQ:357780
|
KR |
|
I
|
InfoMark Co Ltd
KOSDAQ:175140
|
KR |
|
Xebra Brands Ltd
OTC:XBRAF
|
CA |
|
G
|
Grand Pharmaceutical Group Ltd
HKEX:512
|
HK |
|
C
|
Cyrela Brazil Realty SA Empreendimentos e Participacoes
OTC:CYRBY
|
BR |
|
Aubay SA
PAR:AUB
|
FR |
|
CSI Solar Co Ltd
SSE:688472
|
CN |
|
Cochin Minerals and Rutile Ltd
BSE:513353
|
IN |
|
Opera Ltd
NASDAQ:OPRA
|
NO |
|
C
|
Compugates Holdings Bhd
KLSE:COMPUGT
|
MY |
|
Japan System Techniques Co Ltd
TSE:4323
|
JP |
|
Mori Hills Reit Investment Corp
TSE:3234
|
JP |
|
M
|
Mondelez International Inc
SGO:MDLZ
|
US |
|
H
|
HCA Healthcare Inc
SWB:2BH
|
US |
|
C
|
CI Banco SA Institucion de Banca Multiple FF/00939
BMV:TERRA13
|
MX |
|
A
|
Adtran Networks SE
XMUN:ADV
|
DE |
|
A
|
Allianz Saudi Fransi Cooperative Insurance Company SJSC
SAU:8040
|
SA |
|
C
|
Crizac Ltd
NSE:CRIZAC
|
IN |
|
Omron Corp
TSE:6645
|
JP |
|
E
|
Eksun Gida Tarim Sanayi ve Ticaret AS
IST:EKSUN.E
|
TR |
|
Kingston Resources Ltd
ASX:KSN
|
AU |
|
W
|
Woory Industrial Co Ltd
KOSDAQ:215360
|
KR |
|
Pioneer Bancorp Inc
NASDAQ:PBFS
|
US |
Relative Value
There is not enough data to reliably calculate the relative value of SAVA.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
SAVA
Relative Value
Base Case
Not Available
Multiples Across Competitors
SAVA Competitors Multiples
Cassava Sciences Inc Competitors
Cassava Sciences Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Cassava Sciences Inc
NASDAQ:SAVA
|
87.9m USD | 0 | -0.8 | 0.2 | 0.2 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
856.7B USD | 13.1 | 41.5 | 28 | 29.9 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.8B USD | 6 | 21.1 | 14.7 | 18.1 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.3B CHF | 4 | 18.9 | 11.2 | 12.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
216.4B GBP | 4.9 | 28.3 | 15.7 | 22.2 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
282.6B USD | 4.3 | 15.5 | 9.6 | 11.7 | |
| CH |
|
Novartis AG
SIX:NOVN
|
222.2B CHF | 5.1 | 20.5 | 12.7 | 16.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.3 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.4B USD | 2.5 | 19.7 | 7.6 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
115.7B USD | 2.4 | 16.4 | 7 | 8.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
